Infusion of CD3/CD28 costimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance engraftment.

Saved in:
Bibliographic Details
Title: Infusion of CD3/CD28 costimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance engraftment.
Authors: Hexner EO; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Luger SM; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Reshef R; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Jeschke GR; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Mangan JK; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Frey NV; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Frank DM; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Richman LP; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Vonderheide RH; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Aqui NA; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Rosenbach M; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Zhang Y; Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, Pennsylvania., Chew A; Center for Cellular Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Loren AW; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Stadtmauer EA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Levine BL; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Center for Cellular Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., June CH; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Center for Cellular Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Emerson SG; Columbia College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, New York., Porter DL; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Source: American journal of hematology [Am J Hematol] 2016 May; Vol. 91 (5), pp. 453-60. Date of Electronic Publication: 2016 Apr 04.
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1096-8652
DOI:10.1002/ajh.24303